share_log

金斯瑞生物科技：自願性公告: 傳奇生物宣佈發佈首份ESG報告

GENSCRIPT BIO: VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES PUBLICATION OF INAUGURAL ESG REPORT

香港交易所 ·  Mar 19 20:40
Summary by Futu AI
金斯瑞生物科技股份有限公司（「金斯瑞生物科技」）於2024年3月19日宣布其非全資附屬公司傳奇生物科技股份有限公司（「傳奇生物」）發布了首份環境、社會和管治（ESG）報告。該報告概述了傳奇生物的ESG計劃，包括符合永續會計準則委員會生物技術和製藥行業標準的報告、ESG數據收集和披露路線圖，以及未來成長領域。傳奇生物強調了對患者、員工和社區的承諾，並期待在未來幾年繼續推進ESG發展。該ESG報告已於傳奇生物科技網站公開。本公告亦提醒投資者注意前瞻性陳述的風險，並建議在買賣證券時審慎行事。
金斯瑞生物科技股份有限公司（「金斯瑞生物科技」）於2024年3月19日宣布其非全資附屬公司傳奇生物科技股份有限公司（「傳奇生物」）發布了首份環境、社會和管治（ESG）報告。該報告概述了傳奇生物的ESG計劃，包括符合永續會計準則委員會生物技術和製藥行業標準的報告、ESG數據收集和披露路線圖，以及未來成長領域。傳奇生物強調了對患者、員工和社區的承諾，並期待在未來幾年繼續推進ESG發展。該ESG報告已於傳奇生物科技網站公開。本公告亦提醒投資者注意前瞻性陳述的風險，並建議在買賣證券時審慎行事。
Kingsley Biotechnology Co., Ltd. (“Kingsley Biotechnology”) announced on 19 March 2024 that its non-wholly-owned subsidiary Legendary Biotechnology Co., Ltd. (“Legendary Biotech”) has issued its first Environmental, Social and Governance (ESG) Report. THE REPORT OUTLINES LEGENDARY BIOS' ESG PROGRAM, INCLUDING REPORTS THAT MEET SUSTAINABILITY COMMITTEE BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY STANDARDS, ESG DATA COLLECTION AND DISCLOSURE ROADMAP, AND AREAS FOR FUTURE GROWTH. Legendary Bio emphasizes commitment to patients, staff and the community and looks forward to continuing to drive ESG development in the coming years. The ESG report has been published on the Legendary Biotechnology website. The announcement also reminds investors to be aware of the risks associated with forward-looking statements and advises to exercise caution when trading securities.
Kingsley Biotechnology Co., Ltd. (“Kingsley Biotechnology”) announced on 19 March 2024 that its non-wholly-owned subsidiary Legendary Biotechnology Co., Ltd. (“Legendary Biotech”) has issued its first Environmental, Social and Governance (ESG) Report. THE REPORT OUTLINES LEGENDARY BIOS' ESG PROGRAM, INCLUDING REPORTS THAT MEET SUSTAINABILITY COMMITTEE BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY STANDARDS, ESG DATA COLLECTION AND DISCLOSURE ROADMAP, AND AREAS FOR FUTURE GROWTH. Legendary Bio emphasizes commitment to patients, staff and the community and looks forward to continuing to drive ESG development in the coming years. The ESG report has been published on the Legendary Biotechnology website. The announcement also reminds investors to be aware of the risks associated with forward-looking statements and advises to exercise caution when trading securities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.